Biopharmaceutical company AVEO Pharmaceuticals (NASDAQ:AVEO) is among the trending tickers of the day on Yahoo Finance, increasing by 28.49% by 3:00 pm EST following rumors that AstraZeneca PLC (NYSE:AZN) will acquire the company in Q2 2019.
According to Seeking Alpha, representatives from various large investment banks believe AstraZeneca will soon make a move to acquire AVEO, which is nearing FDA approval for its Fotivda (tivozanib) kidney cancer medication. The price of the acquisition could be anywhere between $800 million to $1.2 billion USD.
The M&A speculation has caused the AVEO Pharmaceuticals stock price to ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.